切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2024, Vol. 18 ›› Issue (05) : 473 -476. doi: 10.3877/cma.j.issn.1674-3946.2024.05.001

专家述评

不断提高分化型甲状腺癌根治性切除规范化
王宇1, 徐芳泉1, 周旋1, 姚晓峰1, 李强2,()   
  1. 1. 300060 天津,天津医科大学肿瘤医院颌面耳鼻喉肿瘤科,天津市头颈部肿瘤基础与转化医学重点实验室;300060 天津,国家恶性肿瘤临床医学研究中心,天津市恶性肿瘤临床医学研究中心,天津市肿瘤防治重点实验室;300060 天津,药物成药性评价与系统转化重点实验室
    2. 300060 天津,国家恶性肿瘤临床医学研究中心,天津市恶性肿瘤临床医学研究中心,天津市肿瘤防治重点实验室;300060 天津,天津医科大学肿瘤医院肝胆肿瘤科
  • 收稿日期:2024-04-22 出版日期:2024-10-26
  • 通信作者: 李强

Improve the standardization of radical resection of differentiated thyroid cancer

Yu Wang1, Fangquan Xu1, Xuan Zhou1, Xiaofeng Yao1, Qiang Li2,()   

  1. 1. Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin 300060, China;National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China;National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China
    2. National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China;Department of Hepatobiliary Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China
  • Received:2024-04-22 Published:2024-10-26
  • Corresponding author: Qiang Li
  • Supported by:
    Young Elite Scientists Sponsorship Program by CAST(YESS20220023 to YW); the National Natural Science Foundation of China(82073010); National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine(QZ23-5); Tianjin medical key discipline construction project(TJYXZDXK-009)
引用本文:

王宇, 徐芳泉, 周旋, 姚晓峰, 李强. 不断提高分化型甲状腺癌根治性切除规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 473-476.

Yu Wang, Fangquan Xu, Xuan Zhou, Xiaofeng Yao, Qiang Li. Improve the standardization of radical resection of differentiated thyroid cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(05): 473-476.

甲状腺癌是头颈部常见肿瘤,近年来始终呈现上升趋势。分化型甲状腺癌在甲状腺癌中极其常见,因此分化型甲状腺癌的诊疗规范直接关系到甲状腺癌整体治疗水平。目前分化型甲状腺癌主要以外科手术治疗为主,公认的手术方式有甲状腺全切/近全切、甲状腺单侧腺叶切除。为了减少二次手术的心理及经济负担,东亚地区主张至少进行病侧中央区淋巴结清扫。cN1b+为侧颈淋巴结清扫指征,但其清扫范围仍然存在争议。

Thyroid cancer is a common tumor in the head and neck. It has been showing an upward trend in recent years. Differentiated thyroid cancer(DTC) is extremely common in thyroid cancer, so the diagnosis and treatment of DTC is directly related to the overall treatment level of thyroid cancer. At present, surgical treatment is the primary treatment,and the currently accepted surgical methods include total/near-total thyroidectomy and unilateral thyroidectomy. To reduce the psychological and economic burden of the second operation, the East Asian region advocates central lymph node dissection on the affected side. cN1b+ is an indication for lateral neck dissection, but the extent of dissection is still controversial.

[11]
Haugen BRAlexander EKBible KC,et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid2016,26(1):1-133.
[12]
Filetti SDurante CHartl D,et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J]. Ann Oncol2019,30(12):1856-1883.
[13]
Tuttle RMHaddad RBall DW,et al. Thyroid carcinoma,version 2.2014[J]. J Natl Compr Canc Netw2014,12(12):1671-1680.
[14]
Beal SHChen SLSchneider PD,et al. An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma[J]. Am Surg2010,76(1):28-32.
[15]
Machens AHauptmann SDralle H. Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer[J]. Surgery2009,145(2):176-181.
[16]
韦伟,李朋. 甲状腺癌颈淋巴结清扫术常见并发症及其防治[J]. 中国实用外科杂志2017,37(09):970-973.
[17]
徐震纲,刘绍严. 分化型甲状腺癌颈侧区淋巴结清扫专家共识(2017版)[J]. 中国实用外科杂志2017,37(09):985-991.
[18]
王恩彤. 分化型甲状腺癌颈清扫术的选择[J]. 中华耳鼻咽喉头颈外科杂志2012,47(06):522-525.
[19]
宁玉东,王薇,朱桂全,等. 甲状腺乳头状癌前上纵隔颈淋巴结清扫的治疗现状[J]. 国际耳鼻咽喉头颈外科杂志2020,44(01):25-28.
[20]
贺青卿,李小磊,庄大勇. 机器人甲状腺手术的发展现状和思考[J]. 中华内分泌外科杂志2017,11(05):356-358.
[1]
田文,姚京,郗洪庆,等. 中国腹腔镜甲状腺癌手术20年回顾与展望[J/CD]. 中华普外科手术学杂志(电子版)2021,15(06):598-602.
[2]
Sung HFerlay JSiegel RL,et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin2021,71(3):209-249.
[3]
Barney BMHitchcock YJSharma P,et al. Overall and cause-specifi c survival for patients undergoing lobectomy,near-total,or total thyroidectomy for diff erentiated thyroid cancer[J]. Head Neck2011,33(5):645-649.
[4]
Haigh PIUrbach DRRotstein LE. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer[J]. Ann Surg Oncol2005,12(1):81-89.
[5]
Mendelsohn AHElashoff DAAbemayor E,et al. Surgery for papillary thyroid carcinoma: is lobectomy enough?[J]. Arch Otolaryngol Head Neck Surg2010,136(11):1055-1061.
[6]
Mao JZhang QZhang H,et al. Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis[J]. Front Endocrinol(Lausanne)2020,11:265.
[7]
朱精强,雷建勇,李根棚. 甲状腺癌颈侧区淋巴结清扫局部解剖及临床应用[J]. 中国实用外科杂志2017,37(09):948-952.
[8]
Liu CXiao CChen J,et al. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients[J]. BMC Cancer2019,19(1):622.
[9]
孙辉,李世杰,付言涛,等. 分化型甲状腺癌功能性或传统性颈淋巴结清扫的利弊[J/CD]. 中华普外科手术学杂志(电子版)2018,12(06):455-457.
[10]
赫捷,程颖,樊嘉,等. 中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021[J]. 肿瘤预防与治疗2021,34(12):1164-1201.
[1] 何羽. 腔镜微创手术治疗分化型甲状腺癌的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 456-458.
[2] 宋红霞, 吴玩呈. 内镜下甲状腺手术切口入路发展的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 470-472.
[3] 游涛建, 任林, 马宇. cT1-2N0期PTMC经口腔前庭入路腔镜甲状腺切除术后引流与否的可行性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 311-314.
[4] 吴波, 郑永明, 杜世强. SPECT/CT及血清sTg水平预测甲状腺癌术后131I治疗患者淋巴结转移风险的价值分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 212-216.
[5] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[6] 袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAFV600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[7] 崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[8] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[9] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[10] 黄汇, 朱信强. 131I治疗45岁以下分化型甲状腺癌的疗效及影响因素[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 627-630.
[11] 武帅, 吴佼星, 王方舟, 杨沛泽, 董顺斌, 王铮, 仵正. 胰腺腺泡细胞癌诊断与治疗[J]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 487-491.
[12] 韦德令, 蒋佳君, 徐邦浩, 王继龙, 朱海, 卢婷婷, 张灵, 曾晶晶, 郭雅, 文张. 显微外科肝动脉重建在累及第一肝门胆管癌外科治疗的应用[J]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 350-356.
[13] 陈立华. 中小型前庭神经鞘瘤治疗方式选择的原则和依据[J]. 中华脑科疾病与康复杂志(电子版), 2024, 14(01): 1-7.
[14] 刘通, 李菲, 朱莹, 王蓓. 剪切波弹性成像对甲状腺癌术后放射性碘治疗损伤唾液腺腺体的评估[J]. 中华诊断学电子杂志, 2024, 12(02): 80-84.
[15] 中国抗癌协会食管癌专业委员会. 机器人辅助食管切除术中国临床专家共识(2023版)[J]. 中华胸部外科电子杂志, 2024, 11(01): 1-15.
阅读次数
全文


摘要